Form 4: Rapid Micro Biosystems Director, David Hirsch, Receives Stock Options and Restricted Stock Units

Director David Hirsch of Rapid Micro Biosystems, Inc. reports the acquisition of stock options and restricted stock units.

Summary

• On May 23, 2024, David Hirsch, a director of Rapid Micro Biosystems, Inc., was granted 14,300 shares of Class A Common Stock as restricted stock units (RSUs).
• These RSUs will vest on the earlier of the first anniversary of the grant date or the day before the next annual meeting, provided Hirsch remains in continuous service.
• Hirsch also acquired options to purchase 28,650 shares of Class A Common Stock at an exercise price of $0.82 per share.
• These options also vest on the earlier of the first anniversary of the grant date or the day before the next annual meeting, contingent on continuous service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options and RSUs is a standard practice that aligns the director's interests with those of the shareholders, incentivizing long-term value creation. There are no immediate negative implications.

Positives

• The grant of RSUs and stock options to a director aligns their interests with those of the shareholders.
• The vesting conditions encourage continued service and commitment to the company.

Future Outlook

The vesting of the RSUs and stock options is contingent upon the director's continued service with the company.

Industry Context

Stock options and restricted stock units are common forms of executive compensation in the biotechnology industry, aligning management's interests with shareholder value and incentivizing long-term performance.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors in publicly traded companies, particularly in growth-oriented sectors like biotechnology.
• Companies such as Repligen Corporation and Danaher Corporation also utilize stock options and restricted stock units to incentivize their executives and directors.
• The vesting schedules, typically one year or aligned with annual meetings, are consistent with industry norms to ensure continued service and commitment.

Stakeholder Impact

• Shareholders may view the grant of RSUs and stock options positively, as it aligns the director's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates